Clinical trial
Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk…
NCT00096187 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00096187 |
|---|---|
| Title | Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy |
| Official title | A Phase II Trial of Pemetrexed (ALIMTA®, LY231514, IND #40061) as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Tumor |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gestational Trophoblastic Tumor |
| Intervention type | Drug |
| Interventions | pemetrexed disodium |
| Enrollment | 55 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 23, 2007 |
| First posted | Nov 9, 2004 |
| Last update posted | Apr 12, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: